Drugs News and Research

RSS

H1N1 flu vaccine now available at CVS/pharmacy locations throughout California

CVS/pharmacy announced today that it has expanded the availability of H1N1 flu vaccine to more than 220 stores throughout the State of California.

6 Jan 2010

First Edition: January 5, 2010

Today's headlines focus on the Democratic plans to advance the health bill compromise process and the latest on the nation's health spending.

5 Jan 2010

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.

5 Jan 2010

Despite economic downturn, Russia still represents a promising healthcare market

Despite uncertain economic environment, Russia still represents a promising healthcare market with strong potential for further growth.

5 Jan 2010

Formatech selects ViroMed’s VM206 for Fillanthropy Program

Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed’s VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed’s upcoming clinical trials.

5 Jan 2010

CRT&T presents unique approach to solve issues presented to pharmaceutical executives

The Clinical Research Trends and Technology Forum (CRT&T) presents a unique approach to solving the issues presented to pharmaceutical executives. CRT&T blends educational keynotes and roundtables focusing on standards of care, quality processes and workflow with exposure to the newest and most innovative technologies on the market through one-on-one business meetings and networking events.

5 Jan 2010

Physicians fail to provide pain treatment for fear of prescription drug abuse

Millions of Americans with significant or chronic pain associated with their medical problems are being under-treated as physicians increasingly fail to provide comprehensive pain treatment - either due to inadequate training, personal biases or fear of prescription drug abuse.

5 Jan 2010

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo.

5 Jan 2010

"Nanoworms" and doxorubicin loaded hollow nanoparticles to fight cancer

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

5 Jan 2010

Scientists identify the cause of age-related muscle loss

If you're an aging baby boomer hoping for a buffer physique, there's hope. A team of American scientists from Texas and Michigan have made a significant discovery about the cause of age-related muscle atrophy that could lead to new drugs to halt this natural process. This

5 Jan 2010

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

5 Jan 2010

Significant opportunity for alternative ulcerative colitis biological therapy

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.

5 Jan 2010

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

5 Jan 2010

ART publishes impressive data on its bioresorbable stent

Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

5 Jan 2010

Use of botulinum type A toxins may offer cost efficient alternative to serotonin reuptake inhibitors

According to an article in the January 2010 edition of Drugs In Dermatology (abstract available at http://jddonline.com ), the use of botulinum type A toxins such as Botox and Dysport may offer a cost efficient alternative to the use of selective serotonin reuptake inhibitors.

5 Jan 2010

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

Research shows licorice root might be effective in fighting antibiotic-resistant infections

A team of scientists from the University of Texas Medical Branch and Shriners Hospitals for Children show how a compound from licorice root (glycyrrhizin from Glycyrrhiza glabra) might be an effective tool in battling life-threatening, antibiotic-resistant infections resulting from severe burns.

5 Jan 2010

NPR examines future of U.S. global AIDS strategy

NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.

5 Jan 2010

New York Times examines U.S. H1N1 reponse

As the number of H1N1 (swine flu) cases in the U.S. continues to wane, the New York Times reflects on how federal officials handled the pandemic and other contributing factors.

5 Jan 2010

AP series examines worldwide impact of drug resistance

The Associated Press reports on how the misuse of drugs worldwide has contributed to drug-resistant diseases in a series of articles following a six-month investigation by the news service.

5 Jan 2010

Drugs News and Research

H1N1 flu vaccine now available at CVS/pharmacy locations throughout California

First Edition: January 5, 2010

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

Despite economic downturn, Russia still represents a promising healthcare market

Formatech selects ViroMed’s VM206 for Fillanthropy Program

CRT&T presents unique approach to solve issues presented to pharmaceutical executives

Physicians fail to provide pain treatment for fear of prescription drug abuse

Scientists develop mucus-penetrating biodegradable nanoparticles to deliver drugs over time

"Nanoworms" and doxorubicin loaded hollow nanoparticles to fight cancer

Scientists identify the cause of age-related muscle loss

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Significant opportunity for alternative ulcerative colitis biological therapy

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

ART publishes impressive data on its bioresorbable stent

Use of botulinum type A toxins may offer cost efficient alternative to serotonin reuptake inhibitors

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Research shows licorice root might be effective in fighting antibiotic-resistant infections

NPR examines future of U.S. global AIDS strategy

New York Times examines U.S. H1N1 reponse

AP series examines worldwide impact of drug resistance

Drug Discovery - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News